INSIGHTS ON DRUG DEVELOPMENT

• Integrated QC As A Development Strategy: Reducing Late-Stage Analytical Risk

  Learn how early QC integration, proactive analytical risk management, and cross-functional collaboration can improve validation readiness, reduce development surprises, strengthen release testing predictability, and help protect critical clinical manufacturing timelines.

• Improving API Solubility Using Spray Drying With Polyvinyl Alcohol

  Enhancing the solubility of poorly soluble APIs is vital for improving bioavailability. Discover how advanced formulation techniques like hot-melt extrusion and spray drying can overcome this challenge.

• Cracking Complexity: Learnings From 70+ Bispecific Antibody Programs

  The goal is practical: help development teams make early decisions that balance speed, quality, and risk and support a smoother path to the clinic.

• Right From The Start: Smarter Developability For Stronger Formulations

  Early developability assessment integrates manufacturability, QbD, flexible formulations, and CDMO support to cut risk, speed development, and enable scalable, robust drugs.

• New Approaches To Tailored Release Profiles

  7/7/2025

  Tailored drug release is evolving from formulation tactic to precision therapy strategy, optimizing timing, site, and rate of delivery for improved patient outcomes.

• Grace Capabilities Update February 2026: AI Drug Development

  3/2/2026

  Discover support for your next small molecule drug substance program and learn how artificial intelligence and machine learning tools can be applied to accelerate API development.

• Drug Development Readiness: Interactive Checklist And RACI

  7/27/2026

  Early decisions can have long-lasting consequences for development timelines, cost, risk, and overall probability of success. Engaging the appropriate disciplines early helps avoid downstream surprises and rework.

• CDMOs - Key Collaborators In Streamlining Drug Development

  12/12/2025

  Accelerating biologics development requires more than speed. Discover how the right CDMO partnership can streamline processes and help you reach the market faster without sacrificing control.

• Why Reshoring Is An Essential Strategy For ADC Supply Chain Security

  2/24/2026

  Biotechs reshoring their supply chains to Western regions to mitigate risk and improve reliability require experienced partners to effectively manage these complex transitions.